Multi-omics mendelian randomization integrating GWAS and eQTL data revealed potential drug target for irritable bowel syndrome. Ke H, Chen W, Zhang Q, Liu Z, et al. Front Genet 2026;17:1798264.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ke H, Chen W, Zhang Q, Liu Z, et al. Multi-omics mendelian randomization integrating GWAS and eQTL data revealed potential drug target for irritable bowel syndrome. Front Genet 2026;17:1798264.
PMID: 42232515